Microbot Medical
MBOT

股本结构

单位：万股
公告日期 2025-02-11 2025-02-04 2025-01-10 2025-01-07 2025-01-06 2025-03-10
证券总股本 3474.45 2864.12 2803.07 2424.21 2024.21 2065.14
普通股本 3474.45 2864.12 2803.07 2424.21 2024.21 2065.14
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-02-11 2025-01-31 2025-01-10 2025-01-07 2025-01-03 2024-12-04
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-02-11 3474.45 未披露
更多>>
Common Stock Offered 6,103,289 shares by the company
2025-02-11
2025-02-04 2864.12 未披露 定期报告 2025-01-31
2025-01-10 2803.07 未披露
更多>>
Common stock offered 3,788,550 shares by the company
2025-01-10
2025-01-07 2424.21 未披露
更多>>
Common stock offered 4,000,001 shares by the company
2025-01-07
2025-01-06 2024.21 未披露 定期报告 2025-01-03
2025-03-10 2065.14 未披露 定期报告 2024-12-04
2024-11-13 1693.23 未披露 定期报告 2024-11-11
2024-11-06 1693.19 未披露 定期报告 2024-10-25
2024-11-13 1665.14 未披露
更多>>
From June 30, 2024 to September 30, 2024 Issuance of common stock under the at-the-market offering program, net of issuance costs
2024-09-30
2024-08-14 1650.44 未披露 定期报告 2024-08-09
2024-07-10 1596.56 未披露 定期报告 2024-07-02
2024-06-04 1596.56 未披露
更多>>
Common stock offered 1,566,669 shares by the company
2024-06-04
2024-02-20 1439.90 未披露 定期报告 2024-02-16
2024-01-12 1339.30 未披露 定期报告 2024-01-11
2023-07-11 1170.73 未披露 定期报告 2023-07-07
2023-06-28 1170.73 未披露
更多>>
Common Stock Offered 624,618 shares by the company
2023-06-28
2023-06-28 1108.27 未披露 定期报告 2023-06-23
2023-06-05 1046.30 未披露
更多>>
Common Stock Offered by the company 701,756 shares
2023-06-06
2023-06-05 999.57 未披露
更多>>
Common Stock Offered by the company 975,000 shares
2023-05-24
2023-05-23 878.62 未披露
更多>>
Common Stock Offered by the company 655,569 shares
2023-05-23
2023-03-31 813.06 未披露 定期报告 2023-03-30
2022-10-24 789.06 未披露
更多>>
Common Stock Offered 782,495 shares by company
2022-10-25
2020-11-16 710.81 未披露
更多>>
From June 30, 2020 to September 30, 2020 Exercise of options
2020-09-30
2020-05-15 710.33 未披露
更多>>
From December 31, 2019 to March 31, 2020 Exercise of options Cancellation of treasury common stock
2020-03-31
2020-04-14 718.56 未披露
更多>>
From December 31, 2018 to December 31, 2019 Issuance of common stock and warrants net of issuance costs Cashless exercise of warrants
2019-12-31
2019-12-30 628.47 未披露 定期报告 2019-12-30
2019-12-30 533.23 未披露 定期报告 2019-12-27
2019-12-27 436.93 未披露 定期报告 2019-12-24
2019-05-15 430.77 未披露
更多>>
From December 31, 2018 to March 31, 2019 Issuance of common stock and warrants net of issuance expenses
2019-03-31
2019-04-01 430.76 未披露 定期报告 2019-03-28
2019-02-08 430.77 未披露 定期报告 2019-02-05
2019-04-01 301.23 0.06
更多>>
From December 31, 2017 to December 31, 2018 Shares issued as consideration-vendor Exercise of options Conversion of preferred A shares to common stock
2018-12-31
2018-12-17 301.23 未披露 定期报告 2018-12-14
2018-11-08 297.57 未披露 定期报告 2018-11-07
2018-11-14 225.46 0.06
更多>>
From December 31, 2017 to September 30, 2018 Shares issued as consideration-vendor Exercise of options Conversion of preferred A shares to common stock
2018-09-30
2018-09-04 291.47 未披露
更多>>
On September 4, 2018, as approved by the stockholders of Microbot Medical Inc. (the “Company”) at the annual meeting of the Company’s stockholders held on September 4, 2018 (the “Annual Meeting”), the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a one-for-15 reverse stock split of the Company’s common stock (the “Certificate of Amendment”). As a result of the reverse stock split, every 15 shares of the Company’s old common stock will be converted into one share of the Company’s new common stock.
2018-09-05
2018-08-14 4372.04 0.10
更多>>
from December 31, 2017 to June 30, 2018 Shares issued as consideration-vendor Exercise of options Conversion of preferred A shares to common stock
2018-06-30
2018-05-15 4212.04 未披露 定期报告 2018-05-14
2018-05-15 3141.76 0.25
更多>>
From December 31, 2017 to March 31, 2018 Conversion of preferred A shares to common stock
2018-03-31
2018-04-02 4212.04 未披露 定期报告 2018-03-30
2018-04-02 2988.03 0.40
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock Share-based compensation Exercise of options Cashless exercise of warrants Conversion of preferred A shares to common stock
2017-12-31
2017-11-14 3860.53 未披露 定期报告 2017-11-10
2017-11-14 2630.25 0.70
更多>>
from December 31, 2016 to September 30, 2017 Extinguishment of convertible notes and issuance of preferred shares Conversion of preferred A shares to Common stock Issuance of Common Stock Share based compensation Cashless Exercise of warrants
2017-09-30
2017-08-11 3480.53 未披露 定期报告 2017-07-24
2017-08-14 2360.25 0.97
更多>>
from December 31, 2016 to June 30, 2017 Extinguishment of convertible notes and issuance of preferred shares Conversion of preferred A shares to Common stock Issuance of Common Stock Share based compensation Cashless Exercise of warrants
2017-06-30
2017-05-15 2795.13 未披露 定期报告 2017-05-12
2017-05-15 2725.13 0.97
更多>>
from December 31, 2016 to March 31, 2017 Issuance of Common Stock Exercise of warrants
2017-03-31
2017-03-21 2725.13 未披露 定期报告 2017-03-16
2017-03-21 1584.81 0.97
更多>>
From December 31, 2015 to December 31, 2016 Cancellation of ordinary shares and issuance of preferred shares Effect of reverse recapitalization Transaction costs incurred in reverse recapitalization A 1-for-9 reverse stock split of its outstanding common stock will be effective at November 29, 2016 The Company's common stock at a ratio of 1-for-12. Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Monday, May 9, 2016
2016-12-31
2016-11-29 180.66 未披露
更多>>
A 1-for-9 reverse stock split of its outstanding common stock will be effective at November 29, 2016
2016-11-29
2016-11-03 1625.96 未披露
更多>>
From December 31, 2015 to September 20, 2016 Issuance of common stock and warrants, net of issuance cost of $890,487 Issuance of common stock through exercise of warrants, net of issuance cost of $195,000 Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise and net settlement of restricted stock units The Company's common stock at a ratio of 1-for-12. Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Monday, May 9, 2016
2016-09-20
2016-05-10 1160.19 未披露
更多>>
The Company's common stock at a ratio of 1-for-12. Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Monday, May 9, 2016
2016-05-09
2015-11-02 10880.77 未披露 定期报告 2015-10-22
2015-11-02 10858.93 未披露 定期报告 2015-09-30
2015-08-06 10813.33 未披露 定期报告 2015-06-30
2015-05-05 10509.78 未披露
更多>>
In April 2015, we raised gross proceeds of approximately $25 million through a public offering of 35,715,000 Units.
2015-04-30
2015-04-30 6937.65 未披露 定期报告 2015-04-17
2015-05-05 6931.15 未披露 定期报告 2015-03-31
2015-03-13 6928.85 未披露 定期报告 2015-02-24
2015-03-13 6872.98 未披露
更多>>
from December 31, 2013 to October 31, 2014 Issuance of common stock and warrants, net of issuance cost of $1,335,327 Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise and net settlement of restricted stock units
2014-10-31
2014-11-13 6866.03 未披露 定期报告 2014-09-30
2014-08-12 6863.78 未披露 定期报告 2014-07-31
2014-08-12 5696.72 未披露 定期报告 2014-06-30
2014-05-14 5551.44 未披露 定期报告 2014-05-01
2014-04-30 5549.52 未披露 定期报告 2014-04-17
2014-03-13 5541.91 未披露 定期报告 2014-03-03
2014-03-13 5513.83 未披露
更多>>
from December 31, 2012 to December 31, 2013 Issuance of common stock and warrants, net of issuance cost of $2,051,699 Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise of director stock options Exercise and net settlement of restricted stock units Common stock issued as consideration in the acquisition of a patent portfolio
2013-12-31
2013-12-27 5513.77 未披露 定期报告 2013-12-18
2013-10-31 5497.12 未披露 定期报告 2013-10-25
2013-11-05 4204.48 未披露 定期报告 2013-09-30
2013-08-07 4130.43 未披露 定期报告 2013-07-25
2013-08-07 4126.05 未披露 定期报告 2013-06-30
2013-05-10 3898.01 未披露 定期报告 2013-05-07
2013-05-10 3888.76 未披露 定期报告 2013-03-31
2013-03-21 3887.76 未披露 定期报告 2013-03-04
2013-03-21 3750.63 未披露
更多>>
from December 31, 2011 to December 31, 2012 Issuance of common stock and warrants, net of issuance cost of $900,992 Common stock for external services Common stock issued pursuant to employee benefit plan Compensation expense from grant of options, restricted stock units and stock (fair value) Exercise of director stock options Exercise and net settlement of restricted stock units
2012-12-31
2012-11-08 3744.03 未披露 定期报告 2012-10-26
2012-11-08 3501.83 未披露 定期报告 2012-09-30
2012-08-08 3041.04 未披露 定期报告 2012-08-06
2012-08-08 2537.76 未披露 定期报告 2012-06-30
2012-05-10 2532.92 未披露 定期报告 2012-05-08
2012-05-10 2344.49 未披露 定期报告 2012-03-31
2012-03-15 2329.49 未披露 定期报告 2012-03-02
2012-03-15 2242.80 未披露
更多>>
from Dec 31,2010 to Dec 31,2011 Issuance of common stock and warrants, net of issuance cost of $1,522,083 Common stock issued pursuant to employee benefit plan Compensation expense from grant of options, restricted stock units and stock (fair value) Exercise of employee and director stock options Exercise and net settlement of restricted stock units
2011-12-31
2011-11-03 1432.69 未披露 定期报告 2011-11-01
2011-11-03 1428.39 未披露 定期报告 2011-09-30
2011-08-05 1387.99 未披露 定期报告 2011-08-02
2011-07-06 1384.66 未披露 定期报告 2011-07-01
2011-08-05 1386.56 未披露 定期报告 2011-06-30
2011-05-10 13782.79 未披露 定期报告 2011-05-05
2011-05-10 13774.35 未披露 定期报告 2011-03-31
2011-03-11 13742.72 未披露 定期报告 2011-03-07
2011-03-11 12731.29 未披露
更多>>
from December 31, 2009 to December 31, 2010 Issuance of common stock, net of issuance cost of $480,835 Common stock issued pursuant to employee benefit plan Exercise of employee and director stock options Exercise and net settlement of restricted stock units Stock retired from settlement agreement
2010-12-31
2010-11-03 12702.99 未披露 定期报告 2010-11-01
2010-11-03 12696.95 未披露 定期报告 2010-09-30
2010-08-09 12720.47 未披露 定期报告 2010-08-06
2010-08-09 12716.09 未披露 定期报告 2010-06-30
2010-03-11 11927.19 未披露 定期报告 2010-03-10
2010-03-11 11834.96 未披露
更多>>
From December 31, 2008 to December 31, 2009 Issuance of common stock and warrants, net of issuance cost of $1,351,487 Common stock issued for acquisition of SCS Common stock issued for licensing agreements Common stock issued pursuant to employee benefit plan Exercise of employee and director stock options Exercise and net settlement of restricted stock units Exercise of warrants
2009-12-31
2009-03-16 9554.31 未披露 定期报告 2009-03-05
2009-03-16 9494.56 未披露
更多>>
From December 31, 2007 to December 31, 2008 Issuance of common stock and warrants, net of issuance cost of $1,432,539 Common stock issued for licensing agreements Common stock issued pursuant to employee benefit plan Exercise of employee and director stock options
2008-12-31
2008-03-14 8073.25 未披露 定期报告 2008-02-29
2008-03-14 8068.11 未披露
更多>>
From December 31, 2006 to December 31, 2007 Issuance of common stock related to equity financing net of issuance cost of $297,465 Common stock issued for licensing agreements Common stock issued pursuant to employee benefit plan Exercise of employee stock options Exercise of warrants
2007-12-31
2007-03-15 7862.57 未披露 定期报告 2007-02-23
2007-03-15 7804.63 未披露
更多>>
From December 31, 2005 to December 31, 2006 Issuance of common stock related to equity financing net of issuance cost of $2,418,467 Common stock issued for licensing agreements Common stock issued pursuant to employee benefit plan Exercise of employee and consultant stock options Exercise of warrants
2006-12-31
2006-03-16 6540.27 未披露 定期报告 2006-03-07
2006-03-16 6539.60 未披露
更多>>
From December 31, 2004 to December 31, 2005 Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise of employee and consultant stock options Exercise of warrants
2005-12-31
2005-03-15 6241.75 未披露 定期报告 2005-03-08
2005-03-15 6212.94 未披露
更多>>
From December 31, 2003 to December 31, 2004 Issuance of common stock related to equity financing net of issuance cost $2,863,021 Common stock issued for licensing agreements Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise of employee and consultant stock options Exercise of warrants
2004-12-31
2004-04-06 4100.48 未披露 定期报告 2004-03-17
2004-04-06 4099.89 未披露
更多>>
From December 31, 2002 to December 31, 2003 Conversion of redeemable convertible preferred shares to common stock Issuance of common stock related to equity financing net of issuance cost $310,403 Dividends paid to 3% convertible preferred holders in stock Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise of warrants Exercise of employee and consultant stock options
2003-12-31
2000-04-17 1950.66 未披露 定期报告 2000-03-20
2000-04-17 1915.99 未披露
更多>>
From December 31, 1998 to December 31, 1999 Issuance of common stock Issuance of common stock under the stock purchase plan Common stock issued pursuant to employee benefit plan Exercise of stock options
1999-12-31
1999-03-31 1837.41 未披露 定期报告 1999-03-31
1999-03-31 1832.47 未披露
更多>>
From December 31, 1997 to December 31, 1998 Issuance of common stock under the stock purchase plan Common stock issued pursuant to employee benefit plan Issuance of common stock--StemCells Redeemable common stock lapses Exercise of stock options
1998-12-31
1998-03-31 1826.45 未披露 定期报告 1998-03-09
1998-03-31 1808.40 未披露
更多>>
From December 31,1996 to December 31,1997 Issuance of common stock Issuance of common stock under the stock purchase plan Common stock issued pursuant to employee benefit plan Issuance of common stock -- StemCells,Inc Redeemable common stock lapses Exercise of stock options Deferred compensation-- amortization and cancellations
1997-12-31
1997-03-31 1648.58 未披露 定期报告 1997-03-10
1997-03-31 1642.94 未披露
更多>>
From December 31, 1995 to December 31, 1996 Issuance of common stock Issuance of common stock under the stock purchase plan Exercise of warrants Issuance of common stock to consultants and employees Common stock issued pursuant to employee benefit plan Issuance of redeemable common stock Redeemable common stock lapses Exercise of stock options
1996-12-31
1997-03-31 1517.70 未披露
更多>>
From December 31, 1994 to December 31, 1995 Issuance of common stock Exercise of stock options
1995-12-31
Common Stock Offered 6,103,289 shares by the company
Common stock offered 3,788,550 shares by the company
Common stock offered 4,000,001 shares by the company
From June 30, 2024 to September 30, 2024 Issuance of common stock under the at-the-market offering program, net of issuance costs
Common stock offered 1,566,669 shares by the company
Common Stock Offered 624,618 shares by the company
Common Stock Offered by the company 701,756 shares
Common Stock Offered by the company 975,000 shares
Common Stock Offered by the company 655,569 shares
Common Stock Offered 782,495 shares by company
From June 30, 2020 to September 30, 2020 Exercise of options
From December 31, 2019 to March 31, 2020 Exercise of options Cancellation of treasury common stock
From December 31, 2018 to December 31, 2019 Issuance of common stock and warrants net of issuance costs Cashless exercise of warrants
From December 31, 2018 to March 31, 2019 Issuance of common stock and warrants net of issuance expenses
From December 31, 2017 to December 31, 2018 Shares issued as consideration-vendor Exercise of options Conversion of preferred A shares to common stock
From December 31, 2017 to September 30, 2018 Shares issued as consideration-vendor Exercise of options Conversion of preferred A shares to common stock
On September 4, 2018, as approved by the stockholders of Microbot Medical Inc. (the “Company”) at the annual meeting of the Company’s stockholders held on September 4, 2018 (the “Annual Meeting”), the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a one-for-15 reverse stock split of the Company’s common stock (the “Certificate of Amendment”). As a result of the reverse stock split, every 15 shares of the Company’s old common stock will be converted into one share of the Company’s new common stock.
from December 31, 2017 to June 30, 2018 Shares issued as consideration-vendor Exercise of options Conversion of preferred A shares to common stock
From December 31, 2017 to March 31, 2018 Conversion of preferred A shares to common stock
from December 31, 2016 to December 31, 2017 Issuance of common stock Share-based compensation Exercise of options Cashless exercise of warrants Conversion of preferred A shares to common stock
from December 31, 2016 to September 30, 2017 Extinguishment of convertible notes and issuance of preferred shares Conversion of preferred A shares to Common stock Issuance of Common Stock Share based compensation Cashless Exercise of warrants
from December 31, 2016 to June 30, 2017 Extinguishment of convertible notes and issuance of preferred shares Conversion of preferred A shares to Common stock Issuance of Common Stock Share based compensation Cashless Exercise of warrants
from December 31, 2016 to March 31, 2017 Issuance of Common Stock Exercise of warrants
From December 31, 2015 to December 31, 2016 Cancellation of ordinary shares and issuance of preferred shares Effect of reverse recapitalization Transaction costs incurred in reverse recapitalization A 1-for-9 reverse stock split of its outstanding common stock will be effective at November 29, 2016 The Company's common stock at a ratio of 1-for-12. Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Monday, May 9, 2016
A 1-for-9 reverse stock split of its outstanding common stock will be effective at November 29, 2016
From December 31, 2015 to September 20, 2016 Issuance of common stock and warrants, net of issuance cost of $890,487 Issuance of common stock through exercise of warrants, net of issuance cost of $195,000 Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise and net settlement of restricted stock units The Company's common stock at a ratio of 1-for-12. Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Monday, May 9, 2016
The Company's common stock at a ratio of 1-for-12. Trading of the Company's common stock on the NASDAQ Capital Market will continue, on a split-adjusted basis, with the opening of the markets on Monday, May 9, 2016
In April 2015, we raised gross proceeds of approximately $25 million through a public offering of 35,715,000 Units.
from December 31, 2013 to October 31, 2014 Issuance of common stock and warrants, net of issuance cost of $1,335,327 Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise and net settlement of restricted stock units
from December 31, 2012 to December 31, 2013 Issuance of common stock and warrants, net of issuance cost of $2,051,699 Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise of director stock options Exercise and net settlement of restricted stock units Common stock issued as consideration in the acquisition of a patent portfolio
from December 31, 2011 to December 31, 2012 Issuance of common stock and warrants, net of issuance cost of $900,992 Common stock for external services Common stock issued pursuant to employee benefit plan Compensation expense from grant of options, restricted stock units and stock (fair value) Exercise of director stock options Exercise and net settlement of restricted stock units
from Dec 31,2010 to Dec 31,2011 Issuance of common stock and warrants, net of issuance cost of $1,522,083 Common stock issued pursuant to employee benefit plan Compensation expense from grant of options, restricted stock units and stock (fair value) Exercise of employee and director stock options Exercise and net settlement of restricted stock units
from December 31, 2009 to December 31, 2010 Issuance of common stock, net of issuance cost of $480,835 Common stock issued pursuant to employee benefit plan Exercise of employee and director stock options Exercise and net settlement of restricted stock units Stock retired from settlement agreement
From December 31, 2008 to December 31, 2009 Issuance of common stock and warrants, net of issuance cost of $1,351,487 Common stock issued for acquisition of SCS Common stock issued for licensing agreements Common stock issued pursuant to employee benefit plan Exercise of employee and director stock options Exercise and net settlement of restricted stock units Exercise of warrants
From December 31, 2007 to December 31, 2008 Issuance of common stock and warrants, net of issuance cost of $1,432,539 Common stock issued for licensing agreements Common stock issued pursuant to employee benefit plan Exercise of employee and director stock options
From December 31, 2006 to December 31, 2007 Issuance of common stock related to equity financing net of issuance cost of $297,465 Common stock issued for licensing agreements Common stock issued pursuant to employee benefit plan Exercise of employee stock options Exercise of warrants
From December 31, 2005 to December 31, 2006 Issuance of common stock related to equity financing net of issuance cost of $2,418,467 Common stock issued for licensing agreements Common stock issued pursuant to employee benefit plan Exercise of employee and consultant stock options Exercise of warrants
From December 31, 2004 to December 31, 2005 Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise of employee and consultant stock options Exercise of warrants
From December 31, 2003 to December 31, 2004 Issuance of common stock related to equity financing net of issuance cost $2,863,021 Common stock issued for licensing agreements Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise of employee and consultant stock options Exercise of warrants
From December 31, 2002 to December 31, 2003 Conversion of redeemable convertible preferred shares to common stock Issuance of common stock related to equity financing net of issuance cost $310,403 Dividends paid to 3% convertible preferred holders in stock Common stock issued for external services Common stock issued pursuant to employee benefit plan Exercise of warrants Exercise of employee and consultant stock options
From December 31, 1998 to December 31, 1999 Issuance of common stock Issuance of common stock under the stock purchase plan Common stock issued pursuant to employee benefit plan Exercise of stock options
From December 31, 1997 to December 31, 1998 Issuance of common stock under the stock purchase plan Common stock issued pursuant to employee benefit plan Issuance of common stock--StemCells Redeemable common stock lapses Exercise of stock options
From December 31,1996 to December 31,1997 Issuance of common stock Issuance of common stock under the stock purchase plan Common stock issued pursuant to employee benefit plan Issuance of common stock -- StemCells,Inc Redeemable common stock lapses Exercise of stock options Deferred compensation-- amortization and cancellations
From December 31, 1995 to December 31, 1996 Issuance of common stock Issuance of common stock under the stock purchase plan Exercise of warrants Issuance of common stock to consultants and employees Common stock issued pursuant to employee benefit plan Issuance of redeemable common stock Redeemable common stock lapses Exercise of stock options
From December 31, 1994 to December 31, 1995 Issuance of common stock Exercise of stock options
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。